The results of computer-optimized molecular parametric analysis of chemical toxicity (COMPACT) and Hazard Expert evaluations on 14 established human carcinogens are reported. The concordances between COMPACT and carcinogenicity (71%%) and between HazardExpert and carcinogenicity (57%%) are significantly improved when taken in combination, where all 14 carcinogens are correctly identified by the two systems used in conjunction. However, if a negative energy of the highest occupied molecular orbital (EHOMO) value is regarded as evidence of electrophilic reactivity likely to give rise to mutagenicity and carcinogenicity, then 13//14 (93%%) of the carcinogens are correctly identified by combination with the COMPACT procedure alone. It is possible, therefore, to establish likely carcinogenicity arising from either P450 mediation (CYP1 and CYP2E) or compound electrophilicity via the employment of a straightforward approach to molecular and electronic structure calculation, a process that can be performed in a relatively short time frame (i.e., less than 1 hour per chemical) and at a low cost.
Ashby J , Tennant RW . Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP . Mutat Res1991; 257: 229-306 .
2.
Gold LS , Manley NB , Slone TH , Rohrbach L . Supplement to the carcinogenic potency database (CPDB): results of animal bioassays published in the general literature in 1993 and 1994 and by the national toxicology program in 1995 to 1996 . Environ Health Perspect, 1999; 107(Suppl 4): 527-600 .
3.
Weinstein JN , Myers TG , O'Connor PM , et al. An information-intensive approach to the molecular pharmacology of cancer . Science1997; 275: 343-349 .
4.
Lewis DFV . Computer-assisted methods in the evaluation of chemical toxicity . Rev Comput Chem1992; 3: 173-222 .
5.
Lewis DFV . Comparison between rodent carcinogenicity test results of 44 chemicals and a number of predictive systems . Regul Toxicol Pharmacol1994; 20: 215-222 .
6.
Crump KS , Krewski D , Van Landingham C . Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the national toxicology program . Environ Health Perspect1999; 107: 83-88 .
7.
Duerksen-Hughes PJ , Yang J , Ozcan O . p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing . Environ Health Perspect1999; 107: 805-812 .
8.
Hecht SS , Hochalter JB , Villalta PW , Murphy SE . 20-hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor . Proc Natl Acad Sci USA2000; 97: 12493-12497 .
9.
Gonzalez FJ , Gelboin HV . Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins . Drug Metab Rev1994; 26: 165-183 .
10.
Parke DV . Activation mechanisms of chemical toxicity . Arch Toxicol1987; 60: 5-15 .
11.
Parke DV . The cytochromes P450 and mechanisms of chemical carcinogenesis . Environ Health Perspect1994; 102: 852-853 .
12.
Ioannides C , Lewis DFV . Drugs, diet and disease: mechanistic approaches to cancer, volume 1 Chichester: Ellis Horwood , 1995.
13.
Lewis DFV . COMPACT and the importance of frontier orbitals in toxicity mediated by the cytochrome P450 mono-oxygenase system . Toxicol Modell1995; 1: 85-97 .
14.
Lewis DFV . Frontier orbitals in chemical and biological activity: quantitative relationships and mechanistic implications . Drug Metab Rev1999; 31: 755-816 .
15.
Nelson SD . Metabolic activation and drug toxicity . J Med Chem1982; 25: 753-765 .
16.
Lewis DFV , Moereels H , Lake BG , Ioannides C , Parke DV . Molecular modelling of enzymes and receptors involved in carcinogenesis: QSARs and COMPACT-3D . Drug Metab Rev1994; 26: 261-285 .
17.
Honkakoski P , Negishi M . Regulation of cytochrome P450 (CYP) genes by nuclear receptors . Biochem J2000; 347: 321-337 .
18.
Lewis DFV , Ioannides C , Parke DV . COMPACT and molecular structure in toxicity assessment: a prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the national toxicology program . Environ Health Perspect1996; 104(Suppl 5): 1011-1016 .
19.
Lewis DFV , Bird MG , Parke DV . Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity . Toxicology1997; 118: 93-113 .
20.
Lewis DFV , Ioannides C , Parke DV . An improved version of the COMPACT procedure for the evaluation of P450-mediated chemical activation . Drug Metab Rev1998; 30: 709-737 .
21.
Lewis DFV , Ioannides C , Parke DV . Further validation of the COMPACT approach for the prospective safety evaluation of chemicals. Re-evaluation of 200 miscellaneous chemicals by comparison with rodent carcinogenicity data from the US NCI/NTP . Mutat Res1998; 412: 41-54 .
22.
Lewis DFV . COMPACT: a structural approach for the modelling of the biological activity of xenobiotics . J Chem Technol Biotechnol2001; 76: 1-8 .
23.
Warshawsky D . Polycyclic aromatic hydrocarbons in carcinogenesis . Environ Health Perspect1999; 107: 317-319 .
24.
Lewis DFV . Quantitative structure-activity relationships in substrates, inducers and inhibitors of cytochrome P4501 (CYP1) . Drug Metab Rev1997; 29: 589-650 .
25.
Ioannides C , Parke DV . The cytochrome P4501 gene family of microsomal proteins and their role in the metabolic activation of chemicals . Drug Metab Rev1990; 22: 1-85 .
26.
Ioannides C , Parke DV . Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis . Drug Metab Rev1993; 25: 485-501 .
27.
Lewis DFV . On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics . Biochem Pharmacol2000; 60: 293-306 .
28.
Sarver JG , White D , Erhardt P , Bachmann K . Estimating xenobiotic half-lines in humans from rat data: influence of log P . Environ Health Perspect1997; 105: 1204-1209 .
29.
Lewis DFV , Lake BG , Bird MG , et al. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the CYP2E1 isoform . Xenobiotica2000: 30: 1-25 .
30.
Kehrer JP . Free radicals as mediators of tissue injury and disease . Crit Rev Toxicol1993; 23: 21-48 .
31.
Oberley LW , Oberley TD . Reactive oxygen species in the aetiology of cancer. In Ioannides C , Lewis DFV eds. Drugs, diet and disease: mechanistic approaches to cancer, volume 1. Chichester: Ellis Horwood , 1995: 47-63.
32.
Orr WC , Sohal RS . Extension of life-span by over expression of superoxide dismactase and catalase in Drosophila melanogaster . Nature1994; 263: 1128-1130 .
33.
Martin AP , Palumbi SR . Body size, metabolic rate, generation time and the molecular clock . Proc Natl Acad Sci USA1993; 90: 4087-4091 .
34.
Lijinsky W . Life-span and cancer: the induction time of tumours in diverse animal species treated with nitrosodiethylamine . Carcinogenesis1993; 14: 2373-2375 .
35.
Zhukov A , Ingelman-Sundberg M . Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH cytochrome P450 reductase . Biochem J1999; 340: 453-458 .
36.
Guengerich FP , Johnson WW . Kinetics of ferric cytochromes P450 reaction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems . Biochemistry1997; 36: 14741-14750 .
37.
Lorenz J , Glatt HR , Fleischmann R , Ferlinz R , Oesch F . Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydro lase and glutathione S-transferase activities in sub-cellular fractions of lung and liver . Biochem Med1984; 32: 43-56 .
38.
Johnson W , Hart RW , Leakey JA . Effects of caloric restriction on expression of testicular cytochrome P450 enzymes associated with metabolic activation of carcinogens . Arch Biochem Biophys1996; 335: 42-52 .
39.
Seng JE , Gandy J , Turturro A , et al. Effects of caloric restriction on expression of testicular cytochrome P450 enzymes associated with metabolic activation of carcinogens . Arch Biochem Biophys1996; 335: 42-52 .
40.
Liu PT , Ioannides C , Shavila J , Symons AM , Parke DV . Effects of ether anaesthesia and fasting in various cytochrome P450 of rat liver and kidney . Biochem Pharmacol1993; 45: 871-877 .
41.
Corton JC , Lapinskas PJ , Gonzalez FJ . Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators . Mutat Res2000; 448: 139-151 .
42.
Lake BG . Mechanisms of carcinogenicity of peroxisome-proliferating drugs and chemicals . Annu Rev Pharmacol Toxicol1995; 35: 483-507 .
43.
Waxman DJ . P450 gene induction by structurally diverse xeno-chemicals: central role of nuclear receptors CAR, PXR and PPAR . Arch Biochem Biophys1999; 369: 11-23 .
44.
Rendic S , DiCarlo FJ . Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors . Drug Metab Rev1997; 29: 413-580 .
45.
Moore LB , Parks DJ , Jones SA , et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands . J Biol Chem2000; 275: 15122-15127 .
46.
Pascussi J-M , Drocourt L , Fabre J-M , Maurel P , Vilarem M-J . Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes,: synergistic increase of CYP3A4 induction by pregnane X receptor activators . Mol Pharmacol2000; 58: 361-372 .
47.
Lewis DFV , Ioannides C , Schulte-Hermann R , Parke DV . Quantitative structure activity relationships in a series of indogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis . J Steroid Biochem Mol Biol2000; 74: 179-185 .
48.
Paine AJ . Heterogeneity of cytochrome P450 and its toxicological significance . Hum Exp Toxicol1995; 14: 1-7 .
49.
Neubert D . Vulnerability of the endocrine system to xenobiotic influence . Regul Toxicol Pharmacol1997; 26: 9-29 .
50.
Gonder JC , Proctor RA , Will JA . Genetic differences in oxygen toxicity are correlated with cytochrome P450 inducibility . Proc Natl Acad Sci USA1985; 82: 6315-6319 .
51.
Kukielka E , Cederbaum AI . DNA strand cleavage as a sensitive assay for the production of hydroxyl radicals by microsomes: role of cytochrome P450 2E1 in the increased activity after ethanol treatment . Biochem J1994; 302: 773-779 .
Nebert DW , Duffy JJ . How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, and in environmental toxicity, cancer and oxidative stress . Biochem Pharmacol1997; 53: 249-254 .
54.
Lewis DFV , Ioannides C , Parke DV . A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies . Hum Exp Toxicol1998; 17: 577-586 .
55.
Lewis DFV , Ioannides C , Parke DV . Cytochromes P450 and species difference in xenobiotic metabolism and activation of carcinogens . Environ Health Perspect1998; 106: 633-641 .
56.
Ennever FK , Noonan TJ , Rosenkranz HS . The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans . Mutagenesis1987; 2: 73-78 .
57.
Selkirk JK , Soward SM . Compendium of abstracts from long-term cancer studies reported by the National Toxicology Program . Environ Health Perspect1993; 101(Suppl 1): whole issue.
Jacobs MN , Lewis DFV . An examination of recent findings from Seveso on reproductive effects, and mechanisms of dioxin toxicity . Hum Exp Toxicol1998; 17: 469-534 .
60.
Beresford AP , Ellis, WJ , Ayrton J , Johnson MA , Lewis DFV . Cytochrome P4501A (CYP1A) induction in rat and man by the benzodioxino derivative, fluparoxan . Xenobiotica1997; 27: 159-173 .
61.
Hahn ME . The aryl hydrocarbon receptor: a comparative perspective . Comp Biochem Physiol C Toxicol Pharmacol1998; 121: 23-53 .
62.
Hankinson O . The aryl hydrocarbon receptor complex . Annu Rev Pharmacol Toxicol1995; 35: 307-340 .
63.
Landers JP , Bunce NJ . The Ah receptor and the mechanism of dioxin toxicity . Biochem J1991; 276: 273-287 .
64.
Huff J , Lucier G , Tritscher A . Carcinogenicity of TCDD: experimental mechanistic and epidemiologic evidence . Annu Rev Pharmacol Toxicol1994; 34: 343-372 .
65.
Whitlock JP . Induction of cytochrome P4501A1 . Annu Rev Pharmacol Toxicol1999; 39: 103-125 .
66.
Guengerich FP . Human cytochrome P450 enzymes, In Ortiz deMontellano PR ed. Cytochrome P450. New York, NY: Plenum , 1995: 473-535.
67.
Guengerich FP . Cytochrome P450 3A4: regulation and role in drug metabolism . Annu Rev Pharmacol Toxicol1999; 39: 1-17 .
